Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125542955 | 12554295 | 5 | F | 201606 | 20160805 | 20160713 | 20160811 | EXP | CN-SA-2016SA126881 | AVENTIS | 15.00 | YR | T | M | Y | 51.00000 | KG | 20160811 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125542955 | 12554295 | 1 | PS | THYMOGLOBULINE | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | 12.22MG/KG TOTALLY 22 VIALS | U | C4180C02 | 103869 | 150 | MG/KG | QD | |||||
| 125542955 | 12554295 | 2 | C | TEICOPLANIN | TEICOPLANIN | 1 | 0 | ||||||||||||
| 125542955 | 12554295 | 3 | C | BIAPENEM | BIAPENEM | 1 | 0 | ||||||||||||
| 125542955 | 12554295 | 4 | C | BUSULFEX | BUSULFAN | 1 | IVGTT (PRECISION INFUSION SET) | 0 | 40.8 | MG | Q6H | ||||||||
| 125542955 | 12554295 | 5 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 2.5 | G | |||||||||
| 125542955 | 12554295 | 6 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0 | 2.6 | G | |||||||||
| 125542955 | 12554295 | 7 | C | PHENYTOIN SODIUM. | PHENYTOIN SODIUM | 1 | Oral | 0 | 100 | MG | TABLET | TID | |||||||
| 125542955 | 12554295 | 8 | C | ALPROSTADIL. | ALPROSTADIL | 1 | IVGTT (PRECISION INFUSION SET) | 0 | 30 | UG | QD | ||||||||
| 125542955 | 12554295 | 9 | C | GANCICLOVIR. | GANCICLOVIR | 1 | IVGTT (PRECISION INFUSION SET) | 0 | .25 | G | Q12H | ||||||||
| 125542955 | 12554295 | 10 | C | CELLCEPT | MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 | Oral | DOSE: 0.5 | 0 | BID | |||||||||
| 125542955 | 12554295 | 11 | C | MESNA. | MESNA | 1 | IVGTT (PRECISION INFUSION SET) | 0 | 1.2 | G | TID | ||||||||
| 125542955 | 12554295 | 12 | C | CYCLOSPORIN A | CYCLOSPORINE | 1 | Oral | 0 | 75 | MG | Q12H | ||||||||
| 125542955 | 12554295 | 13 | C | LINEZOLID. | LINEZOLID | 1 | IVGTT | 0 | 600 | MG | Q12H | ||||||||
| 125542955 | 12554295 | 14 | C | IMIPENEM | IMIPENEM | 1 | IVGTT | 0 | 1 | G | Q8H | ||||||||
| 125542955 | 12554295 | 15 | C | VORICONAZOLE. | VORICONAZOLE | 1 | ROUTE: IVGTT?DOSE: 0.2 | 0 | Q12H |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125542955 | 12554295 | 1 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 4 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 5 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 6 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 7 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 8 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 9 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 10 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 11 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 12 | Bone marrow conditioning regimen |
| 125542955 | 12554295 | 13 | Anti-infective therapy |
| 125542955 | 12554295 | 14 | Anti-infective therapy |
| 125542955 | 12554295 | 15 | Anti-infective therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125542955 | 12554295 | DE |
| 125542955 | 12554295 | OT |
| 125542955 | 12554295 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125542955 | 12554295 | Chest pain | |
| 125542955 | 12554295 | Dyspnoea | |
| 125542955 | 12554295 | Haemoptysis | |
| 125542955 | 12554295 | Lung infection | |
| 125542955 | 12554295 | Nausea | |
| 125542955 | 12554295 | Pulmonary alveolar haemorrhage | |
| 125542955 | 12554295 | Pyrexia | |
| 125542955 | 12554295 | Sepsis | |
| 125542955 | 12554295 | Stenotrophomonas infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125542955 | 12554295 | 1 | 20160630 | 20160703 | 0 | |
| 125542955 | 12554295 | 2 | 201606 | 0 | ||
| 125542955 | 12554295 | 3 | 201606 | 0 | ||
| 125542955 | 12554295 | 4 | 20160628 | 20160629 | 0 | |
| 125542955 | 12554295 | 5 | 20160630 | 20160701 | 0 | |
| 125542955 | 12554295 | 6 | 20160702 | 20160703 | 0 | |
| 125542955 | 12554295 | 7 | 20160627 | 20160627 | 0 | |
| 125542955 | 12554295 | 8 | 20160627 | 20160706 | 0 | |
| 125542955 | 12554295 | 9 | 20160627 | 20160704 | 0 | |
| 125542955 | 12554295 | 10 | 20160627 | 20160627 | 0 | |
| 125542955 | 12554295 | 11 | 20160629 | 20160703 | 0 | |
| 125542955 | 12554295 | 12 | 20160701 | 20160706 | 0 | |
| 125542955 | 12554295 | 13 | 20160623 | 20160706 | 0 | |
| 125542955 | 12554295 | 14 | 20160702 | 20160704 | 0 | |
| 125542955 | 12554295 | 15 | 20160624 | 20160704 | 0 |